Eagle Meds Services
Vosevi (SOFOSBUVIR, VELPATASVIR, and VOXILAPREVIR)
Available to sourceHuman Prescription DrugOncology & Specialty

Vosevi (SOFOSBUVIR, VELPATASVIR, and VOXILAPREVIR)

400 mg/1 / 100 mg/1 / 100 mg/1 · Film-Coated Tablet
By Gilead Sciences, Inc.
NDC
61958-2401
Route
Oral
Therapeutic class
Breast Cancer Resistance Protein Inhibitors [MoA], Breast Cancer Resistance Protein Inhibitors [MoA], HCV NS3/4A Protease Inhibitors [MoA], Hepatitis C Virus NS3/4A Protease Inhibitor , Hepatitis C Virus NS5A Inhibitor , Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor , Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA], Organic Anion Transporting Polypeptide 2B1 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], RNA Replicase Inhibitors [MoA]
Marketing category
NDA

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.

Request this medication

Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.

Requesting
Vosevi (SOFOSBUVIR, VELPATASVIR, and VOXILAPREVIR)
NDC 61958-2401